Login

The Opening Bell marks 25 years of Encavis AG being listed on the stock exchange. 00:10:00

Share On Facebook Share On Twitter

The Chief Executive Officer (CEO) of Encavis AG, Dr Dierk Paskert (61)

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
Insights from Shemara's Three-Decade Journey at Macquarie Group |Shemara Wikramanayake , CEO, Macquarie Group.
00:10:00
Attico Mining: Mid-Tier Copper and Gold Producer with Promising High-Grade VMS Projects
00:10:00
The Surge in Iraq: Strategy, Challenges, and Successes|Jack Keane
00:10:00
Blue Bonds: Unlocking the Blue Economy's Potential - Insights from Matt Lawton and Tongai Kunorubwe at T. Rowe Price
00:10:00
CGN Advisors' New Senior Advisor with 20 Years of Experience | Jamie Bosse, Advisor, CGN Advisors, LLC.
00:10:00
Building Ballistic Ventures|Jake Seid,Founding Partner,Ballistic Ventures
00:10:00
Remon Vos on Yield Trends in Hungary and Romania | Remon Vos, President, CTP NV.
00:10:00
Flucas Ventures is a sector stage and geography agnostic investor|Ashley Flucas,Founder,Flucas Ventures
00:10:00
Chaarat Gold Holdings: Expanding Gold Operations in Former Soviet Union, Positioned for Significant Growth
00:10:00
Mamba Exploration Expands Hyden REE Potential with Widespread Mineralization Confirmed | Mike Dunbar , CEO ,Mamba Exploration.
00:10:00
"Factoring transforms invoices into immediate cash, offering fast payment solutions and benefits for trucking companies."
00:10:00
Guy Hands on Brexit's Impact: U.K. Exports, Investment Strategy, and ESG in M&A | Guy Hands, Chairman, Terra Firma Capital Partners.

© 2017 - Neuhu+